Logotype for High Tide Inc

High Tide (HITI) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for High Tide Inc

Q1 2026 earnings summary

18 Mar, 2026

Executive summary

  • Q1 FY2026 revenue reached CAD 178.3 million ($178.3 million), up 25% year-over-year and 9% sequentially, marking the fastest growth in 10 quarters.

  • Adjusted EBITDA was CAD 11.5 million ($11.5 million), up 62% year-over-year, the fastest pace in 2 years and the second-highest quarter ever.

  • Free cash flow was CAD 2.9 million ($2.9 million) for the quarter and CAD 16.8 million ($16.8 million) over the past 12 months, reversing a negative result last year.

  • Canna Cabana remains the largest cannabis retailer in Canada with 220 locations and a 12% market share across five provinces.

  • Loyalty program membership in Canada grew 47% year-over-year to 2.58 million, with Elite members doubling to 162,000.

Financial highlights

  • Gross profit reached a record $44.4 million, up 25% year-over-year and 4% sequentially.

  • Consolidated gross margin was 25% in Q1, consistent with Q4 and year-over-year; brick-and-mortar segment margin reached 28%, the highest in over three years.

  • Adjusted EBITDA margin was 6% overall and 9% for the brick-and-mortar segment.

  • Annualized revenue per sq ft in Q1 was CAD 1,728 ($1,728), slightly lower year-over-year but above many leading blue-chip retailers.

  • Cash and equivalents at quarter-end was CAD 46.4 million ($46.4 million); total debt stood at CAD 64.5 million.

Outlook and guidance

  • Targeting 20–30 new stores in Canada in 2026, mostly organic, with a long-term goal to exceed 350 stores and reach 3 million loyalty members, including 1 million elite.

  • White label products expected to grow from 1.6% to 20% of sales over five years.

  • Remexian gross margins in Germany expected to reach 20–25% as Canadian biomass arrives.

  • Exploring entry into the U.K. market within 12 months and ongoing M&A opportunities.

  • U.S. e-commerce recovery expected to continue, with potential growth from Medicare/Medicaid CBD pilot programs.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more